DANA FEUILLET: Open Payments
NPI 1689076515 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 27 payments from 7 companies in 2025. Trend: 2023 $792 · 2024 $471 · 2025 $597
Food & beverage: $518Education: $79
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 10 | $172 |
| Astellas Pharma US Inc | 4 | $157 |
| Sage Therapeutics, LLC | 4 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $76 |
| Supernus Pharmaceuticals, Inc. | 2 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Organon LLC | 1 | $11 |
Products named: ZURZUVAE, Veozah, Mirena, Qelbree, GEMTESA, Lynkuet, MYFEMBREE, NEXPLANON.
Industry payments across MD — which companies pay providers there.
